Tetravalent Dengue Vaccine TV005 (TetraVax-DV)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tetravalent Dengue Vaccine TV005 (TetraVax-DV), covering 2018-04-02 to 2018-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age [Phase 1]